Local anomalous drug diffusion at healthy-cancer tissue surface and data-driven tumor growth model prediction
- Author
- Maria Ghita, Dana Copot (UGent) , Charlotte Billiet, Dirk Verellen (UGent) and Clara Ionescu (UGent)
- Organization
- Abstract
- This paper discusses reliable yet minimal computational models for predicting the patient's response to anticancer multi-drug combined therapy. The distribution of the drugs into the local heterogeneity of healthy-tumor tissues can be translated into mathematical models. Ideally, these should best describe the physiological processes and physical mechanisms, together with the interactions between the contributing components of the tumor growth dynamic system. Our previously proposed pharmacokinetic-pharmacodynamic (PKPD) mathematical model is revisited for different spatio-temporal fractional drug diffusion patterns. In particular, we examine the specific diffusion-related factors that limit drug effect through the tumor's surface. The ability of the tumor growth PKPD model to predict patient responsiveness was evaluated using prior radiation therapy data in a patient with lung cancer. This study shows that the effect of anomalous diffusion mechanisms within tumor tissue should be considered while modeling the dose-response relationship for optimal results of cancer therapies.
- Keywords
- Tumor growth model prediction, Drug Diffusion, Pharmacokinetic-Pharmacodynamic (PKPD)
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 3.02 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HA6Y57ZEC28PCGT0TRSYWPEV
- MLA
- Ghita, Maria, et al. “Local Anomalous Drug Diffusion at Healthy-Cancer Tissue Surface and Data-Driven Tumor Growth Model Prediction.” 2023 AMERICAN CONTROL CONFERENCE, ACC, IEEE, 2023, pp. 2867–72, doi:10.23919/ACC55779.2023.10156537.
- APA
- Ghita, M., Copot, D., Billiet, C., Verellen, D., & Ionescu, C. (2023). Local anomalous drug diffusion at healthy-cancer tissue surface and data-driven tumor growth model prediction. 2023 AMERICAN CONTROL CONFERENCE, ACC, 2867–2872. https://doi.org/10.23919/ACC55779.2023.10156537
- Chicago author-date
- Ghita, Maria, Dana Copot, Charlotte Billiet, Dirk Verellen, and Clara Ionescu. 2023. “Local Anomalous Drug Diffusion at Healthy-Cancer Tissue Surface and Data-Driven Tumor Growth Model Prediction.” In 2023 AMERICAN CONTROL CONFERENCE, ACC, 2867–72. IEEE. https://doi.org/10.23919/ACC55779.2023.10156537.
- Chicago author-date (all authors)
- Ghita, Maria, Dana Copot, Charlotte Billiet, Dirk Verellen, and Clara Ionescu. 2023. “Local Anomalous Drug Diffusion at Healthy-Cancer Tissue Surface and Data-Driven Tumor Growth Model Prediction.” In 2023 AMERICAN CONTROL CONFERENCE, ACC, 2867–2872. IEEE. doi:10.23919/ACC55779.2023.10156537.
- Vancouver
- 1.Ghita M, Copot D, Billiet C, Verellen D, Ionescu C. Local anomalous drug diffusion at healthy-cancer tissue surface and data-driven tumor growth model prediction. In: 2023 AMERICAN CONTROL CONFERENCE, ACC. IEEE; 2023. p. 2867–72.
- IEEE
- [1]M. Ghita, D. Copot, C. Billiet, D. Verellen, and C. Ionescu, “Local anomalous drug diffusion at healthy-cancer tissue surface and data-driven tumor growth model prediction,” in 2023 AMERICAN CONTROL CONFERENCE, ACC, San Diego, CA, 2023, pp. 2867–2872.
@inproceedings{01HA6Y57ZEC28PCGT0TRSYWPEV,
abstract = {{This paper discusses reliable yet minimal computational models for predicting the patient's response to anticancer multi-drug combined therapy. The distribution of the drugs into the local heterogeneity of healthy-tumor tissues can be translated into mathematical models. Ideally, these should best describe the physiological processes and physical mechanisms, together with the interactions between the contributing components of the tumor growth dynamic system. Our previously proposed pharmacokinetic-pharmacodynamic (PKPD) mathematical model is revisited for different spatio-temporal fractional drug diffusion patterns. In particular, we examine the specific diffusion-related factors that limit drug effect through the tumor's surface. The ability of the tumor growth PKPD model to predict patient responsiveness was evaluated using prior radiation therapy data in a patient with lung cancer. This study shows that the effect of anomalous diffusion mechanisms within tumor tissue should be considered while modeling the dose-response relationship for optimal results of cancer therapies.}},
author = {{Ghita, Maria and Copot, Dana and Billiet, Charlotte and Verellen, Dirk and Ionescu, Clara}},
booktitle = {{2023 AMERICAN CONTROL CONFERENCE, ACC}},
isbn = {{9798350328066}},
issn = {{0743-1619}},
keywords = {{Tumor growth model prediction,Drug Diffusion,Pharmacokinetic-Pharmacodynamic (PKPD)}},
language = {{eng}},
location = {{San Diego, CA}},
pages = {{2867--2872}},
publisher = {{IEEE}},
title = {{Local anomalous drug diffusion at healthy-cancer tissue surface and data-driven tumor growth model prediction}},
url = {{http://doi.org/10.23919/ACC55779.2023.10156537}},
year = {{2023}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: